Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

NCT00781170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Stem Cell Transplantation

Interventions

PROCEDURE: allogeneic hematopoietic SCT

Sponsor

Universitätsklinikum Hamburg-Eppendorf